Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiyi Chu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Trials (London, England)|March 4, 2018
A Bayesian basket trial design using a calibrated Bayesian hierarchical modelYiyi Chu, Ying Yuan
Statistics in Medicine|March 31, 2016
Adaptive dose modification for phase I clinical trialsYiyi Chu, Haitao Pan, Ying Yuan
Applied Energy|August 8, 2022
COVID-19 impacts on residential occupancy schedules and activities in U.S. Homes in 2020 using ATUSDebrudra Mitra, Yiyi Chu, Kristen Cetin
The Science of the Total Environment|May 6, 2018
Predicting daily PM<sub>2.5</sub> concentrations in Texas using high-resolution satellite aerosol optical depthXueying Zhang, Yiyi Chu, Yuxuan Wang, et al.
Plos One|March 8, 2013
Leveraging non-targeted metabolite profiling via statistical genomicsMiaoqing Shen, Corey D Broeckling, Elly Yiyi Chu, et al.
The Oncologist|June 24, 2017
Carcinoid Syndrome and Costs of Care During the First Year After Diagnosis of Neuroendocrine Tumors Among Elderly PatientsChan Shen, Yiyi Chu, Daniel M Halperin, et al.
The Lancet. Oncology|February 28, 2017
Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based studyDaniel M Halperin, Chan Shen, Arvind Dasari, et al.
Pharmacoeconomics|April 24, 2018
Costs of Cancer Care for Elderly Patients with Neuroendocrine TumorsChan Shen, Arvind Dasari, Dian Gu, et al.
Urology|August 30, 2017
Cancer and All-cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-makingStephen B Williams, Jinhai Huo, Yiyi Chu, et al.
Clinical Genitourinary Cancer|August 23, 2017
Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder CancerJinhai Huo, Yiyi Chu, Karim Chamie, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Trials (London, England)|March 4, 2018
A Bayesian basket trial design using a calibrated Bayesian hierarchical modelYiyi Chu, Ying Yuan
Statistics in Medicine|March 31, 2016
Adaptive dose modification for phase I clinical trialsYiyi Chu, Haitao Pan, Ying Yuan
Applied Energy|August 8, 2022
COVID-19 impacts on residential occupancy schedules and activities in U.S. Homes in 2020 using ATUSDebrudra Mitra, Yiyi Chu, Kristen Cetin
The Science of the Total Environment|May 6, 2018
Predicting daily PM<sub>2.5</sub> concentrations in Texas using high-resolution satellite aerosol optical depthXueying Zhang, Yiyi Chu, Yuxuan Wang, et al.
Plos One|March 8, 2013
Leveraging non-targeted metabolite profiling via statistical genomicsMiaoqing Shen, Corey D Broeckling, Elly Yiyi Chu, et al.
The Oncologist|June 24, 2017
Carcinoid Syndrome and Costs of Care During the First Year After Diagnosis of Neuroendocrine Tumors Among Elderly PatientsChan Shen, Yiyi Chu, Daniel M Halperin, et al.
The Lancet. Oncology|February 28, 2017
Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based studyDaniel M Halperin, Chan Shen, Arvind Dasari, et al.
Pharmacoeconomics|April 24, 2018
Costs of Cancer Care for Elderly Patients with Neuroendocrine TumorsChan Shen, Arvind Dasari, Dian Gu, et al.
Urology|August 30, 2017
Cancer and All-cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-makingStephen B Williams, Jinhai Huo, Yiyi Chu, et al.
Clinical Genitourinary Cancer|August 23, 2017
Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder CancerJinhai Huo, Yiyi Chu, Karim Chamie, et al.
Pageof 1